| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A breather from daily antiretroviral therapy for adolescents
|
Ferrand, Rashida A
|
|
2016
|
3 |
9 |
p. e399-e400
nvt p.
|
artikel
|
| 2 |
A cost-effective and focused model for HIV prevention
|
Musenge, Eustasius
|
|
2016
|
3 |
9 |
p. e402-e403
nvt p.
|
artikel
|
| 3 |
Correction to Lancet HIV 2016; 3: e361–87
|
|
|
2016
|
3 |
9 |
p. e408-
1 p.
|
artikel
|
| 4 |
From Durban to Durban: end of AIDS further than hoped
|
Vella, Stefano
|
|
2016
|
3 |
9 |
p. e403-e405
nvt p.
|
artikel
|
| 5 |
Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study
|
Squires, Kathleen
|
|
2016
|
3 |
9 |
p. e410-e420
nvt p.
|
artikel
|
| 6 |
Making waves: safety and efficacy of ART in women
|
Currier, Judith S
|
|
2016
|
3 |
9 |
p. e398-e399
nvt p.
|
artikel
|
| 7 |
Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study
|
McGillen, Jessica B
|
|
2016
|
3 |
9 |
p. e441-e448
nvt p.
|
artikel
|
| 8 |
Pharmacology supports on-demand PrEP
|
Glidden, David V
|
|
2016
|
3 |
9 |
p. e405-e406
nvt p.
|
artikel
|
| 9 |
PrEP introduction for adolescent girls and young women
|
Mathur, Sanyukta
|
|
2016
|
3 |
9 |
p. e406-e408
nvt p.
|
artikel
|
| 10 |
Sexual behaviours, HIV testing, and the proportion of men at risk of transmitting and acquiring HIV in London, UK, 2000–13: a serial cross-sectional study
|
Aghaizu, Adamma
|
|
2016
|
3 |
9 |
p. e431-e440
nvt p.
|
artikel
|
| 11 |
The impact and cost of ending AIDS in Botswana
|
Williams, Brian G
|
|
2016
|
3 |
9 |
p. e409-
1 p.
|
artikel
|
| 12 |
Time for NHS England to accept responsibility for PrEP
|
The Lancet HIV,
|
|
2016
|
3 |
9 |
p. e397-
1 p.
|
artikel
|
| 13 |
Time to accommodate antiretroviral-based HIV prevention
|
Holt, Martin
|
|
2016
|
3 |
9 |
p. e400-e401
nvt p.
|
artikel
|
| 14 |
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial
|
|
|
2016
|
3 |
9 |
p. e421-e430
nvt p.
|
artikel
|
Tijdschrift beschrijving